Bristol-Myers Hepatitis C Therapy With Sovaldi Meets Study Goals

Bristol-Myers Hepatitis C Therapy With Sovaldi Meets Study Goals
Bristol has been focusing on the hepatitis C treatment—called daclatasvir—in combination with Sovaldi following the U.S. Food and Drug Administration's rejection of its new drug application in November for daclatasvir in combination with asunaprevir.
Read more here.

New Hepatitis C Guidelines Hint at High Drug Costs, Access
VIENNA — New hepatitis C treatment guidelines address cutting-edge direct-acting antiviral agents that offer a cure for most patients. Guideline authors from the European Association for the Study of the Liver (EASL) also take on the treatment of …
Read more here.

Sofosbuvir/daclatasvir combination effective treatment for difficult-to-treat
Results presented today at The International Liver Congress™ 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant …
Read more here.

Sofosbuvir and peginterferon/ribavirin demonstrates virologic response rates
The study also evaluated the safety and efficacy of SOF+PEG/RBV for 12 weeks vs SOF+RBV for 16 or 24 weeks in treatment-experienced genotype-2 (GT-2) HCV-infected patients with cirrhosis. GT-2 treatment-experienced patients with cirrhosis had high …
Read more here.

New FDA-approved drug found to be curing people of hepatitis C
They did my lab work and the Hep C was out of my body," she said. Hernandez's treatment started before she needed a transplant. She said it's like a new lease on life. “If Dr. Gilroy hadn't given me this chance, I wouldn't have been able to change my …
Read more here.

Could An Allergy Drug Treat Hepatitis C?
An over-the-counter drug commonly used to treat allergies may one day also contribute to the treatment of hepatitis C, according to new research in mice published in the journal Science Translational Medicine.
Read more here.

CDC Warns More HIV, Hepatitis C Outbreaks Likely Among Drug Users
The Centers for Disease Control and Prevention warns that the U.S. epidemic of opioid abuse could lead to more severe outbreaks of HIV and hepatitis C nationally, much like the outbreak now seen in Indiana. A health advisory the agency released Friday …
Read more here.

European Liver Group Issues New Hep C Treatment Guidelines
Europe has the same approved hep C therapies as the United States, with the addition of Bristol-Myers Squibb's (BMS) Daklinza (daclatasvir), which is under review by the U.S. Food and Drug Administration (FDA) to treat genotype 3 of the virus in …
Read more here.

AbbVie Hepatitis C Drug Granted Priority FDA Review
Also on Friday, Merck & Co. reported late-stage results of its experimental drug combination for treating patients with genotype 1 as well as types 4 and C hepatitis C. In patients with genotype 4, Merck's drug demonstrated a 100% cure rate. Meanwhile …
Read more here.


Leave a Reply